Bill Maughan
Stock Analyst at Clear Street
(0.42)
# 4,170
Out of 5,031 analysts
16
Total ratings
33.33%
Success rate
-22.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WVE Wave Life Sciences | Initiates: Buy | $22 | $7.81 | +181.69% | 1 | Oct 15, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $35.68 | +180.27% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $190.23 | -0.12% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $69.15 | -34.92% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.30 | +552.17% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.47 | +512.24% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $33.56 | +99.64% | 3 | May 9, 2024 | |
| MRNA Moderna | Maintains: Hold | $91 → $106 | $26.01 | +307.54% | 3 | May 3, 2024 | |
| IPSC Century Therapeutics | Maintains: Buy | $22 → $24 | $0.54 | +4,325.59% | 1 | Mar 15, 2024 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $60 | $8.17 | +634.39% | 1 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $94.89 | -52.58% | 1 | Nov 2, 2023 |
Wave Life Sciences
Oct 15, 2025
Initiates: Buy
Price Target: $22
Current: $7.81
Upside: +181.69%
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $35.68
Upside: +180.27%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $190.23
Upside: -0.12%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $69.15
Upside: -34.92%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.30
Upside: +552.17%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.47
Upside: +512.24%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $33.56
Upside: +99.64%
Moderna
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $26.01
Upside: +307.54%
Century Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.54
Upside: +4,325.59%
Bicycle Therapeutics
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $8.17
Upside: +634.39%
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $94.89
Upside: -52.58%